Biotechnology Company Reports and Industry Analysis
Looking for up-to-date information on leading biotechnology companies worldwide? MarketResearch.com provides an extensive collection of company profile reports that offer in-depth insights into a company's organizational set-up and key offerings within the biotech industry. These reports serve as valuable resources for identifying prospective clients and partners, as well as gaining a deeper insight into the strengths and vulnerabilities of competitors.
Biotechnology Company Profiles
- Gain expert insights on prominent competitors like Amgen, Roche, Biogen, Gilead Sciences, AstraZeneca, and Pfizer, and more.
- Quickly obtain revenue breakdowns, strategic analysis, and future growth outlooks to inform your own strategies.
- Browse reports from various research firms including GlobalData, MarketLine, Plunkett Research, Current Partnering, and Worldwide Videotex.
Why Choose MarketResearch.com as Your Partner
Whether you are an experienced industry professional looking to improve your strategies, a consultant guiding clients on their next steps, or a busy executive tasked with critical decisions, MarketResearch.com's biotechnology company reports can be your guide in this dynamic landscape. Your competitors are also seeking opportunities, but with insights from MarketResearch.com, you can gain a powerful advantage.
Biotechnology Company Reports Industry Research & Market Reports
-
Avecho Biotechnology Ltd - Strategy, SWOT and Corporate Finance Report
... structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Avecho Biotechnology Ltd (Avecho), formerly known as Phosphagenics Ltd, is a research-driven biotechnology firm that ... Read More
-
CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report
... structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights CRISPR Therapeutics AG (CRISPR) is a gene editing company. It focuses on the development of ... Read More
-
Foghorn Therapeutics Inc (FHTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... top competitors and compared to the average for all companies within its primary industry. Benchmarking study for Foghorn Therapeutics Inc (FHTX:NAS) includes growth forecast for its primary industry to the year 2029. The purpose of ... Read More
-
Eiger BioPharmaceuticals (EIGR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... and compared to the average for all companies within its primary industry. Benchmarking study for Eiger BioPharmaceuticals (EIGR:NAS) includes growth forecast for its primary industry to the year 2029. The purpose of this report is ... Read More
-
Karuna Therapeutics Inc (KRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... top competitors and compared to the average for all companies within its primary industry. Benchmarking study for Karuna Therapeutics Inc (KRTX:NAS) includes growth forecast for its primary industry to the year 2029. The purpose of ... Read More
-
Nascent Biotech Inc (NBIO:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... top competitors and compared to the average for all companies within its primary industry. Benchmarking study for Nascent Biotech Inc (NBIO:PINX) includes growth forecast for its primary industry to the year 2029. The purpose of ... Read More
-
Xenetic Biosciences (XBIO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... compared to the average for all companies within its primary industry. Benchmarking study for XBiotech (XBIT:NAS) includes growth forecast for its primary industry to the year 2029. The purpose of this report is to provide ... Read More
-
Novartis AG - Digital Transformation Strategies
... cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic diseases, respiratory diseases, immune disorders and infections, etc. The company offers eye care products through its subsidiary, Alcon, and generic medicines through Sandoz. Novartis carries out research in ... Read More
-
ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
-
Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
-
Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
-
GenapSys Inc - Product Pipeline Analysis, 2022 Update
... and delivers the insights of the related molecules. It develops the platform device for chip-based DNA processing which is equipped with a disposable reagent cartridge and a semiconductor-based biosensor that improves processing speed and time. ... Read More
-
Burning Rock Biotech Ltd (BNR) - Product Pipeline Analysis, 2022 Update
... OncoScreen ParpMatch, Lung Core, Colon Core, Prostate Core, Onco Screen Risk, Lung Core, Colon Core, Prostate Core, Breast Core, Thyro Core, Lymph Plasma and BRCA testing. It focuses on NGS (Next-Generation Sequencing) diagnostics solutions for ... Read More
-
Qualizyme Diagnostics GmbH & Co KG - Product Pipeline Analysis, 2022 Update
... include dyed lysozyme substrate and a pH-responsive material for research. The company is also developing point-of-care infection tests for the detection of wound and synovial joint infections. Qualizyme Diagnostics offers contract research and development services ... Read More
-
BioTex Inc - Product Pipeline Analysis, 2022 Update
... procedures in diagnostic, medical device and life sciences industries. It also offers product development, clinical and regulatory, commercialization and contract manufacturing services such as component manufacturing, assembling and packaging, among others. The company serves various ... Read More
-
Predigen Inc - Product Pipeline Analysis, 2022 Update
... disease; advanced signatures for infectious disease in pre-symptomatic detection of viral and bacterial infections, and accurately discriminate among viral infection, bacterial infection, no infection, or co-infection for early treatment and appropriate use of antibiotic and ... Read More
-
Carmell Therapeutics Corp - Product Pipeline Analysis, 2022 Update
... total joint replacement; and tissue healing accelerant against surgical wounds, partial and full thickness grafts and primary healing in chronic wound beds. The company utilizes its PBM technology platform, which cross links lyophilized plasma into ... Read More
-
3D Bio Corp - Product Pipeline Analysis, 2022 Update
... NasaNovo. The company provides bio printing platform which focuses on whole tissue living implants for near term indications. It has lab and factory facilities in Ithaca, New York and engineering workshop in Brooklyn, New York. ... Read More
-
Pear Therapeutics Inc (PEAR) - Product Pipeline Analysis, 2022 Update
... includes reSET-O for the treatment of opioid use disorder (OUD) in conjunction with opioid replacement therapy; Somryst against chronic insomnia; PEAR-004 targeting schizophrenia; and PEAR-006 for treating multiple sclerosis. The company’s PDT platform is developing ... Read More
-
International Directory of Biotechnology Companies 2023
International Directory of Biotechnology Companies 2023 The most comprehensive and accurate Directory of companies and executives in the biotechnology industry Internationally.Extensive profiles of companies and each company's senior officials. Read More
-
European Directory of Biotechnology Companies 2023
... you abreast of the thousands of personnel changes taking place due to company mergers, acquisitions, consolidations, & staff turnover. This Directory is a for anyone who needs to find contacts in the biotechnology throughout Europe. Read More
-
China Biotechnology Directory 2023
... of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published. This powerful Directory is your connection to key decision-makers in the biotechnology industry throughout Asia. Read More
-
USA Directory of Biotechnology Companies 2023
... is one of the most comprehensive & accurate Directory of companies & executives in the biotechnology industry that have ever been published. Hundreds of biotechnology companies & executives working in the industry throughout the USA. Read More
-
Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
Research Assistance
